Chronic pain affects more than 30% of people worldwide, making it one of the most vital areas of clinical research and development. Sponsors developing new treatments have the chance to help millions of patients around the world and deliver truly impactful results. But before these new therapies can reach patients, they must navigate a challenging clinical trial landscape.

The solution? Equip sponsors with faster, smarter tools to evaluate a wider range of trial design characteristics to select a trial that rises to these clinical, tactical, and market access challenges. By simplifying this step, we give the most promising therapies the best opportunity to demonstrate their value and reach the patients without unnecessary delays.

Discover how we recently helped one of our clients do this with East Horizon.